IEFM
IGC icon

IQ EQ Fund Management’s IGC Pharma IGC Stock Holding History

IQ EQ Fund Management’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-102,133
Closed -$54K – 221
2022
Q2 		$54K Buy
102,133
+4,898
+5% +$3.09K 0.01% 198
2022
Q1 		$92K Sell
97,235
-1,482,043
-94% -$1.44M 0.02% 195
2021
Q4 		$1.54M Buy
1,579,278
+165,402
+12% +$222K 0.24% 131
2021
Q3 		$2.09M Buy
1,413,876
+299,461
+27% +$484K 0.32% 100
2021
Q2 		$1.83M Buy
1,114,415
+279,052
+33% +$426K 0.28% 113
2021
Q1 		$1.5M Buy
+835,363
New +$1.52M 0.26% 135

Other funds holding IGC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DP
Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VIA
Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

IQ EQ Fund Management's IGC Position: Q3 2022 in Review

IQ EQ Fund Management sold out of IGC Pharma (IGC) in Q3 2022, closing a stake of 102,133 shares — an estimated $54K sold.

IQ EQ Fund Management first reported a position in IGC in Q1 2021 and held it in 6 quarters. The position peaked at $2.09M in Q3 2021. 26 funds tracked by Wall St. Rank hold IGC as of Q3 2022.

  • IQ EQ Fund Management reported no remaining IGC Pharma position as of Q3 2022 after selling out during the quarter.
  • IQ EQ Fund Management sold 102,133 IGC Pharma shares in Q3 2022, an estimated $54K.
  • IQ EQ Fund Management first reported a position in IGC Pharma in Q1 2021 and held it in 6 quarters.
  • IQ EQ Fund Management's IGC Pharma position peaked at $2.09M in Q3 2021.
  • 26 funds tracked by Wall St. Rank held IGC Pharma as of Q3 2022.

Based on IQ EQ Fund Management's 13F filing for Q3 2022, filed 26 Oct 2022.